November 2 (SeeNews) - Bulgaria's Sopharma issued the following non-consolidated financial figures in a statement to the Bulgarian Stock Exchange (BSE):
9-mo 2009 9-mo 2008 |
Net profit/loss |
30,875,000 |
15,079,000 |
Minority Interest |
0 |
0 |
Pre-tax profit/loss |
34,220,000 |
16,823,000 |
Sales revenue |
143,280,000 |
135,436,000 |
Total revenue |
147,737,000 |
140,408,000 |
Total costs |
113,517,000 |
123,585,000 |
Total assets |
396,261,000 |
378,978,000 |
Capital |
132,000,000 |
132,000,000 |
(1 euro = 1.95583 Bulgarian levs)